The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis.
Conclusions: CXCR2 is an unfavorable predictor in terms of OS and RFS in patients with cancer except for digestive tract cancer and is related with poorer prognostic.
PMID: 29599927 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Ductal Carcinoma | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Hepatocellular Carcinoma | Kidney Cancer | Laryngeal Cancer | Liver Cancer | Lung Cancer | Pancreas | Pancreatic Cancer | Renal Cell Carcinoma | Skin Cancer | Squamous Cell Carcinoma | Study